UCLA Health researchers say study findings uncover Huntington's disease mechanisms and pave new ways to develop treatments.

SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced that the U.S. Food and Drug Administration ...

Huntington's disease (HD), an autosomal-dominant progressive neurological disease with an identified gene mutation, has demonstrated insidious changes in brain morphology, motor control ...

Another new product, the Visium HD Spatial Gene Expression Assay ... the Chan Zuckerberg Initiative, and NIH’s BRAIN Initiative Cell Census Network (BICCN) project. Protagonist Therapeutics ...

A 14-year study tracking NfL levels in people with the HD gene shows this tiny protein can signal disease progression many ...

Celebrate the late Gene Hackman with one of his best movies, which counts among five movies leaving Amazon Prime Video in ...

By Guest Columnist Dr. Stephanie Duguid Our most recent speaker through the Mississippi Health Ambassador Initiative was Dr.

The firm is using single-cell, multiomics analysis to probe tumor samples from very long-term cancer survivors for keys to defeating the disease.

Resilience relies on the brain’s ability to regulate emotion, adapt, and recover. Myelin plasticity helps speed up and stabilize resilient brain responses. Genes like FKBP5 and BDNF affect how people ...

Cedars-Sinai investigators have developed a novel artificial intelligence (AI) model, named DYNA, that accurately ...